Loyola s C diff Journey

Similar documents
C. Difficile Testing Protocol

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer

9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)

Clostridium difficile Infection (CDI) Management Guideline

Clostridium difficile infection surveillance: Applying the case definition

ECHO-Antibiotic Stewardship Program

Clostridium Difficile Infection in Adults Treatment and Prevention

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics

6/14/2012. Welcome! PRESENTATION OUTLINE CLOSTRIDIUM DIFFICILE PREVENTION. Teaming Up to Prevent Infections! 1) Impact. 2) Testing Recommendations

Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate

DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News. Volume 3, Number 6, June 2015

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?

Pros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015

Updates to pharmacological management in the prevention of recurrent Clostridium difficile

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017)

ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

Clostridium difficile Essential information

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments

Clostridium difficile Diagnostic and Clinical Challenges

Clostridium difficile: An Overview

Clostridium difficile

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review

Clostridium Difficile colitismore

Problem Statement. Focal Point: Patient Re-Admitted, 2nd Surgery Required, Stay Extended

Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure

A Pharmacist Perspective

Clostridium difficile Infection: Diagnosis and Management

The Bristol Stool Scale and Its Relationship to Clostridium difficile Infection

Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:

Prevention and Control of Healthcare-Associated Norovirus

An Oral Fecal Transplant for Lunch?- Frankly Speaking EP 53

C Difficile - The Ultimate Challenge: Controlling the Spread

ABSTRACT PURPOSE METHODS

Clostridioides difficile Infection: What s the BIG Stink?

HRET HIIN Diagnostic Error Virtual Event

Treatment of Clostridium Difficile Infection in Community Teaching Hospital: A Retrospective Study

Protocol for the Scottish Surveillance Programme for Clostridium difficile infection.

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE

Infection Prevention & Control Core Skills Level 2

Transmission of Clostridium difficile infections in Belgian hospitals. Marie-Laurence Lambert, MD, PhD

New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility

more intense treatments are needed to get rid of the infection.

CDI The Impact. Disclosures. Acknowledgments. Objectives and Agenda. What s in the Name? 11/14/2012. Lets Talk Numbers

Clostridium difficile Infection (CDI) Guideline

Clostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg?

Ayrshire and Arran NHS Board

C. DIFFICILE UPDATE. Heather Bell, DO Infectious Diseases Physician

CLOSTRIDIUM DIFICILE. Negin N Blattman Infectious Diseases Phoenix VA Healthcare System

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH

Historical Perspective

7/30/2018 C. DIFFICILE UPDATE DISCLOSURE OUTLINE. Heather Bell, DO Infectious Diseases Physician. None to report

Patient Safety Summit 2014

Clinical. Clostridium Difficile: Standard Operating Procedure. Document Control Summary. Contents

Understanding C. diff. atomalliance.org/cdifftraining

What Are Probiotics? PROBIOTICS

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013

SCORES FOR 4 TH QUARTER, RD QUARTER, 2014

Indicator Definition

NHSN Tips for CMS Hospital IQR Program: MRSA Bacteremia and CDI LabID Healthcare Personnel Influenza Vaccination

Nancy Hailpern, Director, Regulatory Affairs K Street, NW, Suite 1000 Washington, DC 20005

HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile

Clostridium difficile

DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit

TREATMENT OF INPATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS

Management of Clostridium Difficile: Total Colectomy versus Colon Sparing Surgery

! Macrolide antibacterial. Fidaxomicin (Dificid ) package labeling. Optimer Pharmaceuticals, Inc. May 2011.

REVISION EFFECTIVE DATE N/A

Safe Patient Care Keeping our Residents Safe

Clostridium difficile Infection (CDI) Guideline Update:

What do I need to tell the doctor BEFORE my child takes this drug? If your child has an allergy to this drug or any part of this drug.

Follow this and additional works at:

Modern approach to Clostridium Difficile Infection

Diarrhoea on the AMU. Dr Chris Roseveare

Hospital-acquired diarrhoea in elderly patients: epidemiology and staff awareness

FIS 2013, Birmingham

Clostridium difficile CRISTINA BAKER, MD, MPH INFECTIOUS DISEASE PARK NICOLLET/HEALTH PARTNERS 11/9/2018

Atypical Presentation of Clostridium Difficille Infection (CDI).

Fecal microbial transplantation

New Antimicrobials and Rapid Diagnostics: Implications for Antibiotic Stewardship

TITLE OF PRESENTATION

Clostridium difficile Infection (CDI)

Infection Prevention and Control in Long Term Care Part 2

Procedure for the Prevention Control and Management of Clostridium difficile Infection in Care Settings in Shetland

Treating and Preventing. C. difficile Infections A Review of the Research for Adults

2018 CNISP HAI Surveillance Case definitions

HEALTHCARE ASSOCIATED INFECTION PREVENTION AND CONTROL REPORT SEPTEMBER 2014

Update in Hospital Medicine. Update in Hospital Medicine 2009

Management of the Hospitalized IBD Patient. Drew DuPont MD

Los Angeles County Department of Public Health: Your Partner in CDI Prevention

Flagyl cdiff treatment duration

DETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE

Long-Term Care Updates

3/23/2012. Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI

Round Robin Highlights of Infection Control Practices

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment.

Transcription:

Loyola s C diff Journey Kevin Smith, MD Associate Chief Medical Officer, Quality & Safety Aziz Ansari, DO Associate Chief Medical Officer, Clinical Optimization/Revenue Integrity

Background Loyola Medicine is on a path towards zero harm, including eliminating hospital acquired infections (HAIs) When we started our journey, we have a much higher than expected rate of hospital onset Clostridium difficile (C diff) infections We recognized that many patients diagnosed with hospital onset C diff actually either presented with infection or likely were colonized with C diff and had loose stools for non-infectious reasons Appropriately identifying patients as community onset/c diff colonization versus hospital onset C diff should allow us to: Improve antibiotic stewardship for existing patients Better decide which interventions can prevent the development of C diff colitis for future patients Success would require both technical and adaptive solutions

Technical Solution C diff Testing Algorithm Patient develops loose or liquid stool *Never send for soft stool 1. Do not send stool for Cdiff testing 2. Continue to monitor patient for diarrhea 1. Patient has clinically significant diarrhea (3 or more episodes of diarrhea within 24 hours) 2. Or patient has cramping, leukocytosis, or ileus Has patient been previously diagnosed with Cdiff during this admission? 1. Do not send C. diff PCR again 2. Start treatment if not already on treatment 3. Escalate treatment if patient is already on treatment 4. Consider ID consult Contact Clinical Approval Team for approval of C. diff PCR test Can patient be removed from laxatives for 48 hours? Is patient on laxatives or colchicine? 1. Order C. diff PCR 2. Start contact plus precautions 1. Do not send C. diff PCR 2. Discontinue laxatives and monitor patient for at least 48 hours Can stool be collected? Cancel isolation order and C. diff PCR test after 24 hours Does diarrhea continue? 1. Order C. diff PCR 2. Use contact plus precautions C. diff PCR sent through Clinical Approval Team approval process Do not order C. diff PCR test and continue with usual care Is test approved? Is C. diff PCR positive? 1. Initiate treatment 2. Do not repeat C. diff PCR for remainder of hospitalization 1. C. diff PCR test is cancelled 2. Remove isolation precautions 3. Monitor for new symptoms 1. Discontinue contact plus precautions and pursue other diagnoses 2. Do not send C. diff PCR for at least 7 days

Testing Stewardship Works Hospital Onset CDI SIR by Quarter 2 1.8 1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0 2016 Q3 2016 Q4 2017 Q1 2017 Q2 SIR 1.691 1.348 1.647 0.947 Target 1.133 1.133 1.133 1.133 CO Onset CDI Cases 69 62 70 96 HO Onset CDI Cases (Observed) 50 36 49 39 HO Onset CDI Cases(Expected) 29.564 26.714 29.755 40.041 Dramatic improvement in our rate with this intervention Starting in 2017 Q2, one of our infection control practitioners proactively contacted nurses to collect loose stool, and physicians to cancel pending C. diff tests if inappropriate

Adaptive Solution Appropriate C diff testing became a drumbeat that we discussed as often as possible Early testing of loose stool (within the first 3 days) Appropriate testing of C diff (after first 3 days) Developed a Clinical Approval Team that reviewed all C diff tests after day 3 of hospitalization to evaluate the appropriateness Also allowed real time education to our physicians Emphasizing C diff allowed consistent messaging and also innovation at the local unit level thing replaces countless hours of conversations, especially with doubters

Standardized Infection Ratio (SIR) 1.8 Clostridium Difficile Infection (CDI) SIR - Hospital-Wide Loyola University Medical Center CDI SIR CDI FY19 Target = 0.40 1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 Our intervention 0 Quarter (O=Number of Observed Infections) Definition: Standardized Infection Ratio (SIR) = Number of Observed Infections / Number of Expected Infections

Rate per 10000 Patient Days Number of Infections Hospital-Wide - Healthcare Onset Clostridium Difficile Infection (CDI) Rate # of CDI Loyola University Medical Center 25 CDI Rate # of CDI Target = 5 25 20 20 15 15 10 10 5 5 0 0 Month (N=Patient Days, CDI=Number of Infections) Definition: Number of patients hospital-wide with healthcare onset (HO) clostridium difficile infections (CDI) per 10,000 patient days.

Summary Our hospital onset C diff rates Standardized Infection Ratio has decreased from 1.6 to 0.4 due to our interventions This improvement has significant implications for the safety of our patients as well as for our reputation and our value based payments We are discussing using the lessons we learned for this process to reducing other HAIs